JESSICA COCKRILL: Open Payments
NPI 1154091387 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,140 in 44 payments from 25 companies in 2025. Trend: 2023 $339 · 2024 $274 · 2025 $1,140
Food & beverage: $965Education: $175
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $143 |
| PFIZER INC. | 6 | $125 |
| Ipsen Biopharmaceuticals, Inc | 2 | $103 |
| Novartis Pharmaceuticals Corporation | 3 | $95 |
| Astellas Pharma US Inc | 3 | $72 |
| GENZYME CORPORATION | 3 | $72 |
| Eisai Inc. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
Products named: XTANDI, KISQALI, Lenvima, SARCLISA, Nubeqa, Padcev, LYNOZYFIC, MI CANCER SEEK.
Industry payments across VA — which companies pay providers there.
